Article
Identification of miRSNPs associated with the risk of multiple myeloma.
International journal of cancer - 1 Feb 2017
Macauda Angelica, Calvetti Diego, Maccari Giuseppe, Hemminki Kari, Försti Asta, Goldschmidt Hartmut, Weinhold Niels, Houlston Richard, Andersen Vibeke, Vogel Ulla, Buda Gabriele, Varkonyi Judit, Sureda Anna, Martinez Lopez Joaquin, Watek Marzena, Butrym Aleksandra, Sarasquete Maria Eugenia, Dudziński Marek, Jurczyszyn Artur, Druzd-Sitek Agnieszka, Kruszewski Marcin, Subocz Edyta, Petrini Mario, Iskierka-Jażdżewska Elzbieta, Raźny Malgorzata, Szombath Gergely, Marques Herlander, Zawirska Daria, Chraniuk Dominik, Halka Janusz, Hove Jacobsen Svend Erik, Mazur Grzegorz, García Sanz Ramón, Dumontet Charles, Moreno Victor, Stępień Anna, Beider Katia, Pelosini Matteo, Manuel Reis Rui, Krawczyk-Kulis Malgorzata, Rymko Marcin, Avet-Loiseau Hervé, Lesueur Fabienne, Grząśko Norbert, Ostrovsky Olga, Jamroziak Krzysztof, Vangsted Annette J, Jerez Andrés, Tomczak Waldemar, Zaucha Jan Maciej, Kadar Katalin, Sainz Juan, Nagler Arnon, Landi Stefano, Gemignani Federica, Canzian Federico
Abstract excerpt
Multiple myeloma (MM) is a malignancy of plasma cells usually infiltrating the bone marrow, associated with the production of a monoclonal immunoglobulin (M protein) which can be detected in the blood and/or urine. Multiple lines of evidence suggest that genetic factors are involved in MM pathogenesis, and several studies have identified single nucleotide polymorphisms (SNPs) associated with the susceptibility to...
Read the complete abstract on PubMed